These findings underscore the enduring impact of transient hyperglycemia on ECs’ transcriptomic and chromatin accessibility profiles, emphasizing the potential utility of pharmacological NRF2 pathway activation in mitigating and reversing the high-glucose–induced transcriptional and epigenetic alterations. Here, NFE2L2 is linked to Hyperglycemia.